These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6143975)

  • 41. Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers.
    Salmon P; Le Cotonnec JY; Galazka A; Abdul-Ahad A; Darragh A
    J Interferon Cytokine Res; 1996 Oct; 16(10):759-64. PubMed ID: 8910759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring of interferon treatment in patients with renal cell carcinoma and bladder carcinoma by oligo-A synthetase assay and determination of immunological parameters.
    Grups JW; Komprecht B
    J Biol Regul Homeost Agents; 1989; 3(3):98-101. PubMed ID: 2516404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon for the therapy of condyloma acuminatum.
    Gall SA; Hughes CE; Trofatter K
    Am J Obstet Gynecol; 1985 Sep; 153(2):157-63. PubMed ID: 3898846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon treatment of anogenital human papillomavirus-related diseases.
    Trofatter KF
    Dermatol Clin; 1991 Apr; 9(2):343-52. PubMed ID: 1711942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Condylomata acuminata in children--detection of HPV 6/11 and 2. Local therapy with interferon-beta hydrogel].
    Fierlbeck G; Rassner G; Pfister H
    Hautarzt; 1992 Mar; 43(3):148-51. PubMed ID: 1315724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intralesional interferon alfa-2b for the treatment of genital warts.
    Welander CE; Homesley HD; Smiles KA; Peets EA
    Am J Obstet Gynecol; 1990 Feb; 162(2):348-54. PubMed ID: 2155531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biological and clinical effects of interferon-beta ser at two doses.
    Borden EC; Rinehart JJ; Storer BE; Trump DL; Paulnock DM; Teitelbaum AP
    J Interferon Res; 1990 Dec; 10(6):559-70. PubMed ID: 2086672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment failure of genital condylomata acuminata in women: role of the male sexual partner.
    Krebs HB; Helmkamp BF
    Am J Obstet Gynecol; 1991 Aug; 165(2):337-9; discussion 339-40. PubMed ID: 1872334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Current treatment of genital condylomas].
    Vilmer C; Cavelier-Balloy B
    Ann Dermatol Venereol; 1987; 114(9):1157-60. PubMed ID: 3324901
    [No Abstract]   [Full Text] [Related]  

  • 51. A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology.
    Hu X; Miller L; Richman S; Hitchman S; Glick G; Liu S; Zhu Y; Crossman M; Nestorov I; Gronke RS; Baker DP; Rogge M; Subramanyam M; Davar G
    J Clin Pharmacol; 2012 Jun; 52(6):798-808. PubMed ID: 21680782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delayed presentation of patients with genital warts.
    Coker DM; Ahmed-Jushuf I; O'Mahony C; Alawattegama AB
    Genitourin Med; 1988 Aug; 64(4):281. PubMed ID: 3169761
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of asymptomatic infection with HTLV-III on the response of anogenital warts to intralesional treatment with recombinant alpha 2 interferon.
    Douglas JM; Rogers M; Judson FN
    J Infect Dis; 1986 Aug; 154(2):331-4. PubMed ID: 3014013
    [No Abstract]   [Full Text] [Related]  

  • 54. A phase I study of recombinant interferon-beta in patients with advanced malignant disease.
    Ravandi F; Estrov Z; Kurzrock R; Breitmeyer JB; Maschek BJ; Talpaz M
    Clin Cancer Res; 1999 Dec; 5(12):3990-8. PubMed ID: 10632330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chlamydia and condylomata acuminata: an update for the nurse practitioner.
    Bourcier KM; Seidler AJ
    J Obstet Gynecol Neonatal Nurs; 1987; 16(1):17-22. PubMed ID: 3643988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topic and systemic administration of natural alfa interferon in the treatment of female and male HPV genital infections.
    Stentella P; Frega A; Di Renzi F; Palazzetti PL; Pachì A
    Clin Exp Obstet Gynecol; 1996; 23(1):29-36. PubMed ID: 8653931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Condylomata acuminata and associated infections--possibilities for therapy with interferon].
    Zwiorek L; Schmidt-Rhode P; Goerke K; Schulz KD
    Zentralbl Gynakol; 1992; 114(8):409-13. PubMed ID: 1325717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of anogenital warts].
    Cervenakov I; Malatinský E; Cervenaková B
    Bratisl Lek Listy; 1984 Apr; 81(4):472-5. PubMed ID: 6713226
    [No Abstract]   [Full Text] [Related]  

  • 59. Recurrent condylomata acuminata treated with recombinant interferon alpha-2a. A multicenter double-blind placebo-controlled clinical trial. Condylomata International Collaborative Study Group.
    Acta Derm Venereol; 1993 Jun; 73(3):223-6. PubMed ID: 8105627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Initial experience with combined interferon-alpha 2B and carbon dioxide laser for the treatment of condylomata acuminata.
    Davis BE; Noble MJ
    J Urol; 1992 Mar; 147(3):627-9. PubMed ID: 1538444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.